Cosmo Bio Company,Limited
Cosmo Bio Company,Limited 3386.T Peers
See (3386.T) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 3386.T | $1,154.00 | +0.44% | 6.58B | 25.62 | $45.04 | +4.35% |
| 4544.T | $3,018.00 | -0.20% | 171.48B | 62.18 | $48.54 | +4.13% |
| 4694.T | $2,920.00 | +1.04% | 113.90B | 18.18 | $160.65 | +3.46% |
| 2395.T | $1,278.00 | -0.70% | 53.21B | 10.80 | $118.28 | +3.89% |
| 2309.T | $2,644.00 | +0.46% | 44.64B | 8.48 | $311.89 | N/A |
| 4671.T | $2,302.00 | +1.45% | 23.38B | 12.73 | $180.84 | +5.42% |
| 2397.T | $1,090.00 | -0.09% | 7.37B | -59.47 | -$18.33 | N/A |
| 7707.T | $202.00 | +1.51% | 5.49B | -10.15 | -$19.90 | N/A |
| 6090.T | $775.00 | +4.87% | 4.52B | 17.28 | $44.84 | +2.03% |
| 9776.T | $1,005.00 | -0.30% | 3.14B | 8.59 | $117.03 | +2.28% |
Stock Comparison
3386.T vs 4544.T Comparison
3386.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 3386.T stands at 6.58B. In comparison, 4544.T has a market cap of 171.48B. Regarding current trading prices, 3386.T is priced at $1,154.00, while 4544.T trades at $3,018.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
3386.T currently has a P/E ratio of 25.62, whereas 4544.T's P/E ratio is 62.18. In terms of profitability, 3386.T's ROE is +0.03%, compared to 4544.T's ROE of -0.01%. Regarding short-term risk, 3386.T is less volatile compared to 4544.T. This indicates potentially lower risk in terms of short-term price fluctuations for 3386.T.